SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,701 | -19.7% | 54,456 | +15.7% | 0.00% | -33.3% |
| Q2 2023 | $984,882 | -11.0% | 47,056 | -10.2% | 0.00% | 0.0% |
| Q1 2023 | $1,106,456 | -18.7% | 52,389 | -2.0% | 0.00% | -25.0% |
| Q4 2022 | $1,360,226 | +22.5% | 53,447 | +15.7% | 0.00% | 0.0% |
| Q3 2022 | $1,110,000 | +32.5% | 46,213 | +6.1% | 0.00% | +100.0% |
| Q2 2022 | $838,000 | -17.2% | 43,574 | -25.1% | 0.00% | 0.0% |
| Q1 2022 | $1,012,000 | -20.6% | 58,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,274,000 | -10.7% | 58,200 | -22.0% | 0.00% | -33.3% |
| Q3 2021 | $1,426,000 | +9.3% | 74,600 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $1,305,000 | +9.1% | 76,000 | +42.1% | 0.00% | 0.0% |
| Q1 2021 | $1,196,000 | +5.8% | 53,500 | +5.3% | 0.00% | 0.0% |
| Q4 2020 | $1,130,000 | +32.5% | 50,800 | -12.1% | 0.00% | +50.0% |
| Q3 2020 | $853,000 | +43.1% | 57,800 | +43.8% | 0.00% | 0.0% |
| Q2 2020 | $596,000 | +47.9% | 40,200 | +9.5% | 0.00% | +100.0% |
| Q1 2020 | $403,000 | +52.7% | 36,700 | +21.9% | 0.00% | 0.0% |
| Q4 2019 | $264,000 | +17.3% | 30,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $225,000 | +25.7% | 30,100 | +56.8% | 0.00% | – |
| Q2 2019 | $179,000 | +80.8% | 19,200 | +2.1% | 0.00% | – |
| Q1 2019 | $99,000 | +54.7% | 18,800 | +30.6% | 0.00% | – |
| Q4 2018 | $64,000 | – | 14,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |